Loss of ARID1A is closely associated with MMR deficiency and MSI in gastric cancer, colorectal cancer, and uterine endometrioid carcinoma (49, 53, 88, 101). This evidence concerns the gene ARID1A and endometrial endometrioid adenocarcinoma.